{"schema_version":"secwatch.filing_event.v1","accession":"0001453687-25-000054","form_type":"8-K","ticker":"RNAC","cik":"0001453687","company_name":"Cartesian Therapeutics, Inc.","filed_at":"2025-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.659479+00:00","generated_at":"2026-05-25T17:25:02.922990+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.0,"confidence":"low","headline":"Cartesian Therapeutics files 8-K with corporate slide deck; no material news evident","bullets":["Slide deck titled 'Pioneering mRNA Cell Therapy for Autoimmunity' dated March 2025 furnished as Exhibit 99.1.","No financial results, pipeline updates, or guidance changes provided in the filing.","The exhibit is furnished under Regulation FD and contains no new material information."],"urls":{"canonical":"https://secwatch.observer/filing/0001453687-25-000054","json":"https://secwatch.observer/filing/0001453687-25-000054.json","markdown":"https://secwatch.observer/filing/0001453687-25-000054.md","text":"https://secwatch.observer/filing/0001453687-25-000054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453687/000145368725000054/0001453687-25-000054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453687/000145368725000054/rnac-20250303.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T17:25:02.922990+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}